
DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse
The recommendations were made during the 66th DCC meeting, held on June 17, 2025, at CDSCO headquarters, New Delhi, under the chairmanship of Dr Rajeev Singh Raghuvanshi, Drugs Controller General (India). Unregulated Access in Private Sector Raises Red …